Ortin Laboratories Ltd - 539287 - Audited Financial Results For The Quarter And Year Ended 31.03.2020
Audited financial results for the Quarter and Year ended 31.03.202030-07-2020
30-07-2020
Ortin Laboratories Ltd - 539287 - Appointment of Company Secretary and Compliance Officer
Appointment of Company Secretary cum Compliance officer24-07-2020
Ortin Laboratories Ltd - 539287 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate u/r 74(5) of SEBI (DP) Regulations, 201814-07-2020
Ortin Laboratories Ltd - 539287 - Shareholding for the Period Ended June 30, 2020
Ortin Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here13-07-2020
Ortin Laboratories Ltd - 539287 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- S Murali Krishna MurthyDesignation :- Managing Director / Whole Time Director11-07-2020
Ortin Laboratories Ltd - 539287 - Board Meeting Intimation for Consideration Of Audited Financial Results For The Quarter And Year Ended 31.03.2020
Ortin Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2020 ,inter alia, to consider and approve audited financial results for the quarter and year ended 31.03.202025-06-2020
Ortin Laboratories Ltd - 539287 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 30.06.2020
Ortin Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve 1. Audited financial veswlts for the quarter and year: ended 31.03. 2020. 2. Any other business with the pemulssian of the Chair.17-06-2020
Ortin Laboratories Ltd - 539287 - Disclosure Of Material Impact Of COVID-19 Pandemic On The Company - Reg.
Disclosure of material impact of COVID-19 pandemic on the Company - Reg.13-06-2020
Ortin Laboratories Ltd - 539287 - Disclosures Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations, 2011
Disclosures under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 201128-05-2020
Ortin Laboratories Ltd - 539287 - Disclosure Under Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 7(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 201516-05-2020